Portal de investigación
- Inicio
- Proyectos y Estudios
- ESTUDIO DE FASE IV, ABIERTO, CRUZADO, DE INTERVENCIÓN PARA COMPARAR LA FACILIDAD DE USO DE TOBRAMICINA POLVO PARA INHALACIÓN FRENTE A TOBRAMICINA SOLUCIÓN PARA INHALACIÓN Y COLISTIMETATO NEBULIZADO PARA EL TRATAMIENTO DE LA INFECCIÓN PULMONAR POR PSEUDOM ONAS AERUGINOSA PULMONAR EN PACIENTES CON FIBROSIS QUÍSTICA.
ESTUDIO DE FASE IV, ABIERTO, CRUZADO, DE INTERVENCIÓN PARA COMPARAR LA FACILIDAD DE USO DE TOBRAMICINA POLVO PARA INHALACIÓN FRENTE A TOBRAMICINA SOLUCIÓN PARA INHALACIÓN Y COLISTIMETATO NEBULIZADO PARA EL TRATAMIENTO DE LA INFECCIÓN PULMONAR POR PSEUDOM ONAS AERUGINOSA PULMONAR EN PACIENTES CON FIBROSIS QUÍSTICA.
Datos básicos
- Protocolo:
- CTBM100C2403
- EUDRACT:
- 2012-001565-33
- NCT:
- Centro:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Año de incio:
- 2013
- Año de finalización:
- 2015
Objetivos del proyecto
Observaciones: Estado Comité: FINALIZADO
Documentos
- No hay documentos
Participantes
Financiadores - Promotores
Resultados del Ensayo Clínico
[Disseminated non-tuberculous mycobacterial infection in a patient with hyper-IgE syndrome].
Romero Rubio MT; (...); Santos Serrano L
Letter. 10.1016/j.anpedi.2013.01.017. 2013
Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.
Ruiz Ramos J; (...); Poveda Andrés JL
Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014
Anidulafungin-Induced Alopecia
Ruiz-Ramos J; (...); Poveda-Andrés JL
Article. 10.1177/1060028014524534. 2014
Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation
Sánchez-Lázaro I; (...); Aliño SF
Article. 10.2217/pgs.15.39. 2015
Burden of serious fungal infections in Spain
Rodriguez-Tudela JL; (...); University of Manchester in association with the LIFE program
Article. 10.1016/j.cmi.2014.07.013. 2015
Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 2015
Clinical experiences with cannabinoids in spasticity management in multiple sclerosis
Lorente Fernández L; (...); Casanova-Estruch B
Article. 10.1016/j.nrl.2013.06.014. 2014
Component-resolved diagnosis: Performance of specific IgE to Alternaria compared to Alt a 1
Nieto M; (...); Mazon A
Letter. 10.1111/pai.12305. 2014
Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice
Lorente-Fernandez, L; (...); Poveda-Andres, JL
Article. 10.1136/ejhpharm-2013-000426. 2015
Cystic fibrosis in adult age
Lerin, M; (...); Alvarez-Sala, R
Article. 10.1016/j.rce.2014.05.001. 2014
Drug Interaction Between Oral Cyclosporine Modified and Iron
Domingo-Chiva, E; (...); Poveda-Andres, JL
Article. 10.1177/1060028013514734. 2014
ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA
Sole A; (...); Casado MA
Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014
EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
Rojas, L.; (...); Alino, S. F.
Article. 2013
Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies
Rojas L; (...); Aliño SF
Article. 10.1038/tpj.2014.38. 2015
EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY
Rojas, L.; (...); Alino, S. F.
Article. 2013
Epidemiology, diagnosis and treatment of fungal respiratory infections in the critically ill patient.
Garnacho-Montero J; (...); Barberán J
Article. 2013
Erratum to "Practical guidelines: lung transplantation in patients with cystic fibrosis".
Hirche TO; (...); ECORN-CF Study Group
Article. 10.1155/2015/698460. 2015
Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.
Marrero-Álvarez P; (...); Poveda-Andrés JL
Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study
Sarmiento, E; (...); Carbone, J
Article. 10.1016/j.healun.2016.10.004. 2017
Evaluation of omalizumab prescription for asthma patients. Adequacy to the recommendations of the regulatory agencies and asthma guidelines
de Rojas, H. F.; (...); Nieto Garcia, A.
Meeting Abstract. 2013
Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors
Ruiz Ramos J; (...); Poveda Andrés JL
Article. 10.1016/j.gastrohep.2014.05.004. 2014
Functional Outcomes After Lung Transplant in Chronic Obstructive Pulmonary Disease
Navarro, JC; (...); Alarcon, JP
Article. 10.1016/j.arbres.2014.06.012. 2015
Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population
Bosó V; (...); Aliño SF
Article. 10.1097/FTD.0b013e3182a94e65. 2014
Hyperkalemia in heart failure patients: current challenges and future prospects
Lopez-Vilella, R; (...); Almenar-Bonet, L
Review. 10.2147/RRCC.S75680. 2016
Incompatibility of undiluted busulfan injection with a needle-free valve
Cueto-Sola, M; (...); Poveda-Andres, JL
Letter. 10.2146/ajhp140111. 2014
Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
Awatade, NT; (...); Amaral, MD
Article. 10.1016/j.ebiom.2014.12.005. 2015
Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.
Rojas LE; (...); Aliño SF
Article. 10.1097/FPC.0b013e3283642fb3. 2013
Nocardia farcinica lung infection in a patient with cystic fibrosis and a lung transplant.
Chacón CF; (...); Ansotegui E
Article. 10.1016/j.redar.2014.04.010. 2015
Possible recurrence of symptoms after discontinuation of omalizumab in anti-IgE-assisted desensitization to egg
Lafuente I; (...); Nieto A
Letter. 10.1111/pai.12259. 2014
Practical guidelines: lung transplantation in patients with cystic fibrosis.
Hirche TO; (...); ECORN-CF Study Group
Article. 10.1155/2014/621342. 2014
Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries
Quittner AL; (...); Barker D
Article. 10.1136/thoraxjnl-2014-205983. 2014
Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy
Eduardo Megias, Juan; (...); Angel Sanz, Miguel
Article. 2014
Progresos en el diagnostico de la alergia.
Nieto A, Nieto M, Mazón A
Abstract of Published Item. 2014
Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.
Valero García S; (...); Poveda Andrés JL
Article. 10.1177/1078155212457964. 2013
Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation
Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.
Article. 10.1016/j.healun.2014.01.392. 2014
SNPs and taxane toxicity in breast cancer patients
Bosó V; (...); Aliño SF
Article. 10.2217/PGS.14.127. 2014
Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
Cantón R; (...); Solé A
Article. 10.1016/j.arbres.2014.09.021. 2015
Spanish Heart Transplant Registry. 29th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure
Gonzalez-Vilchez, F; (...); Representation Equipos Espanoles T
Article. 10.1016/j.recesp.2018.07.020. 2018
Spanish Heart Transplant Registry. 30th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure (1984-2018)
Gonzalez-Vilchez, F; (...); Abella-Anton, R
Article. 10.1016/j.rec.2019.09.005. 2019
Spanish Heart Transplant Registry. 31th Official Report of the Heart Failure Association of the Spanish Society of Cardiology.
González-Vilchez F; (...); Groba Marco MDV
Article. 10.1016/j.rec.2020.06.035. 2020
Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital
Pérez-Cebrián M; (...); Llopis-González A
Article. 2015
Trasplante pulmonar en la linfangioleiomiomatosis esporádica. Estudio de 7 casos.
Ansótegui Barrera E; (...); Padilla Alarcón J
Abstract of Published Item. 10.1016/j.medcli.2013.05.036. 2013
Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature
Lizan, L; (...); Polanco, C
Review. 10.2147/PPA.S67253. 2014